Analysis of complete blood count parameters throughout disease severity in COVID-19 survivors

Authors

  • Tanusha Pathak All India Institute of Medical Science, Bhopal
  • Rachna Parashar Department of Physiology, All India Institute of Medical Science, Bhopal
  • Pragati Raghuwanshi Department of Physiology, All India Institute of Medical Science, Bhopal
  • Deepti Joshi Department of Pathology, All India Institute of Medical Science, Bhopal
  • Ankur Joshi Department of CFM, All India Institute of Medical Science, Bhopal
  • Rajnish Joshi Department of General Medicine, All India Institute of Medical Science, Bhopal
  • Ragini Shrivastava Department of General Medicine, All India Institute of Medical Science, Bhopal

DOI:

https://doi.org/10.15305/ijir.v7i1.373

Abstract

 The pandemic of Coronavirus disease 2019 (COVID-19) represented a scientific and social crisis. Among the most pressing unmet needs for coronavirus disease in 2019 was its unpredictable clinical course, which resulted in an irreversible outcome. The presence of post-acute COVID-19 syndrome in survivors, as well as the exploration of different blood cell counts in Covid 19 survivors, seems to be unclear, and scientific data is still being summarized. Patients can be divided into three categories: mild, moderate, and severe in terms of infection severity. Platelets, white blood cell total count, lymphocytes, neutrophils and hemoglobin levels have all been linked to COVID-19 infection and severity. In this regard, evaluation of hematological abnormalities at the beginning, during and after COVID-19 infection and during COVID-19 that can be indicative of prognosis in the recovery phase. The purpose of this study was to analyze the complete blood picture among COVID-19 survivors & co-relate it with disease severity which can be implemented as a prognostic biomarker of the disease.

Downloads

Published

31-01-2023

Issue

Vol. 7 No. 1 (2023)

Section

Abstracts

License

Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the ‘Indian journal of Inflammation Research’. All the published content, except where otherwise noted, is licensed under Creative Commons license (CC-BY).

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication of the manuscript in IJIR, as it can lead to productive exchanges, as well as earlier and greater citation of published work.